Swiss Biotech Day 2026: AI, Oncology, Microbiome Highlights

Key Takeaways

• Swiss Biotech Day 2026 is underway in Basel, Switzerland, running from May 4-5, 2026.
• The conference features sessions on AI in drug discovery, precision oncology advancements, and the evolving landscape of microbiome therapeutics.
• Presentations include insights from industry leaders at Evotec, Nvidia, and Ferring Pharmaceuticals.

Basel, Switzerland – Swiss Biotech Day 2026 commenced May 4th at the Congress Center Basel, bringing together life science professionals for two days of collaboration and discussion. The conference, which runs through May 5th, features key sessions on artificial intelligence in drug discovery, precision oncology, and microbiome therapeutics.

Started in 2021, Swiss Biotech Day has experienced substantial growth, increasing by 40% annually. The 2025 edition saw over 3,000 participants from 49 countries, including 25 international delegations, solidifying its position as a premier global biotechnology event.

Key Presentations and Sessions

Digital and Health Technologies: AI-Driven Breakthroughs

A pitching session titled "AI-driven breakthroughs from target to therapy" showcased startups leveraging artificial intelligence, digital twins, and advanced biologics. The session highlighted applications ranging from target identification and validation to therapeutic design and clinical acceleration, with a focus on oncology, aging, and related fields.

AI-Powered Pharma R&D: Connecting Data, Labs, and Decisions

A panel discussion, "AI-powered pharma R&D, end-to-end: Connecting data, labs, and decision," addressed strategies for moving AI programs beyond the pilot stage in pharmaceutical research and development. Panelists included Ashiq Khan, Chief Business Officer at Evotec, and Constantin Landers, Life Sciences Lead D-A-CH at Nvidia.

Precision Oncology: MSK-ACCESS and SOPHiA DDM

Discussions centered on the evolution of MSK-ACCESS® powered by SOPHiA DDM™, highlighting the collaboration between SOPHiA GENETICS and Memorial Sloan Kettering. This partnership aims to transform precision oncology by scaling access to advanced diagnostic solutions.

Microbiome-Based Therapies: Data's Role

A panel moderated by Tomas de Wouters, CEO of PharmaBiome, featured Alan Harris, Senior VP Global R&D at Ferring Pharmaceuticals, discussing the critical role of data in shaping the development of microbiome therapeutics.

"Future Stars" Pitch Session

Swiss biotech companies, including MutaDent, Talixeon Therapeutics, Versarys Bioscience, and ZuriEV, presented their innovative solutions spanning therapeutics, diagnostics, and enabling technologies.

IntelligenceRegulatory Impact▾

EMA and MHRA are the agencies to watch. Regulatory relevance reads medium for biotech. Teams should track submission types, designations, and guidance shifts that could move approval timelines.

Market & Investor Implications

Swiss Biotech Day serves as a key indicator of emerging trends and investment opportunities within the European biotechnology sector. The focus on AI, precision oncology, and microbiome therapies reflects the growing importance of these fields in pharmaceutical innovation.

IntelligenceCompetitive Intelligence▾

Competitive pressure is low. Watch which sponsors move first. Benchmark pipeline positioning, differentiation, and partnership scouting against the signals in this story.

What to Watch Next

Keep an eye on partnerships and collaborations announced following the event, as well as clinical trial updates from companies presenting new technologies and therapeutic approaches.

Frequently Asked Questions

• What is Swiss Biotech Day?

  Swiss Biotech Day is a leading biotechnology conference held annually in Basel, Switzerland, fostering international collaboration and partnerships within the life sciences industry.

• When and where is Swiss Biotech Day 2026 taking place?

  Swiss Biotech Day 2026 is being held May 3–5, 2026 (overall event: May 3–8, 2026) at the Congress Center Basel in Basel, Switzerland.

• What are the main topics covered at Swiss Biotech Day 2026?

  Key topics include AI in drug discovery, precision oncology, and microbiome therapeutics.

• Who are some of the key speakers and companies participating?

  Key participants include representatives from Evotec, Nvidia, Ferring Pharmaceuticals, SOPHiA GENETICS, and Memorial Sloan Kettering, among others.

References

• NCSU IES Events. https://ies.ncsu.edu/events/
• Swiss Biotech Day. https://swissbiotechday.ch/wp-content/uploads/2026/04/SBD2026_Conference_Guide_Web.pdf

Related coverage

• Florian Lordick Elected 2026 ESMO President: Implications for Global Oncology
• KRX IR Reference : Executive Summary Plan for SCD NDR (ENG, Jun 2026)
• EMEA 2026 Life Sciences Report: Key Market Shifts for Pharma BD and Investors